Company: CERO
Filing Date: 2025-01-07
Form Type: 424B3
Source: 0001213900-25-001658
Chunk: 8

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-07
Form: 424B3
Chunk 8
---
 as of 12:01 a.m. Eastern Time on January 8,
2025, the Company filed the Charter Amendment and effected a 1-for-100 reverse stock split of its shares of Common Stock (the “Reverse
Stock Split”).

As a result of the Reverse
Stock Split, every 100 shares of the Company’s Common Stock issued or outstanding were automatically reclassified into one validly
issued, fully-paid and non-assessable new share of Common Stock, subject to the treatment of fractional shares as described below, without
any action on the part of the holders. Proportional adjustments were made to the number of shares of Common Stock awarded and available
for issuance under the Company’s equity incentive plans, as well as the exercise price and the number of shares issuable upon the
exercise or conversion of the Company’s outstanding stock options and other equity securities under the Company’s equity incentive
plans. Additionally, all outstanding shares of preferred stock were adjusted in accordance with their terms, which resulted, among other
changes to the preferred stock terms, in proportionate adjustments being made to the number of shares issuable upon exercise of such preferred
stock and to the conversion prices of such preferred stock. All outstanding warrants were also adjusted in accordance with their terms,
which resulted, among other changes to the warrant terms, in proportionate adjustments being made to the number of shares issuable upon
exercise of such warrants and to the exercise and redemption prices of such warrants. The shares of Common Stock outstanding following
the Reverse Stock Split remain fully paid and non-assessable. The Reverse Stock Split did not affect the number of authorized shares of
Common Stock or the par value of the Common Stock.

No fractional shares will
be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive fractional shares as a result
of the Reverse Stock Split will automatically be entitled to receive an additional fraction of a share of Common Stock to round up to
the next whole share.

Trading of the Common Stock
on The Nasdaq Global Market commenced on a split-adjusted basis at market open on January 8, under the existing trading symbol “CERO.”
The new CUSIP number for the Company’s Common Stock following the Reverse Stock Split is 71902K303.

The foregoing description
of the Charter Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the certificate
of amendment, a copy of which is filed as Exhibit 3.1 to